# Kevin Biglan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kevin-biglan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,383 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 43 |
| i10-index | 82 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5034197012 |
| ORCID iD | 0000-0001-5114-3755 |
| Works | 148 |

## Researcher papers

- [Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home](https://scholariq.org/papers/multiple-wearable-sensors-in-parkinson-and-huntington-disease-individuals-a/)
- [Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030](https://scholariq.org/papers/projected-number-of-people-with-parkinson-disease-in-the-most-populous-nations/)
- [Detection of Huntington's disease decades before diagnosis: the Predict-HD study](https://scholariq.org/papers/detection-of-huntington-s-disease-decades-before-diagnosis-the-predict-hd-study/)
- [CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion](https://scholariq.org/papers/cag-repeat-expansion-in-huntington-disease-determines-age-at-onset-in-a-fully/)
- [Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study](https://scholariq.org/papers/detecting-and-monitoring-the-symptoms-of-parkinson-s-disease-using-smartphones-a/)
- [Neurocognitive signs in prodromal Huntington disease.](https://scholariq.org/papers/neurocognitive-signs-in-prodromal-huntington-disease/)
- [Randomized Controlled Clinical Trial of “Virtual House Calls” for Parkinson Disease](https://scholariq.org/papers/randomized-controlled-clinical-trial-of-virtual-house-calls-for-parkinson/)
- [National randomized controlled trial of virtual house calls for Parkinson disease](https://scholariq.org/papers/national-randomized-controlled-trial-of-virtual-house-calls-for-parkinson/)
- [Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's disease](https://scholariq.org/papers/increasing-access-to-specialty-care-a-pilot-randomized-controlled-trial-of/)
- [The past, present, and future of telemedicine for Parkinson's disease](https://scholariq.org/papers/the-past-present-and-future-of-telemedicine-for-parkinson-s-disease/)
- [Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial](https://scholariq.org/papers/virtual-house-calls-for-parkinson-disease-connect-parkinson-study-protocol-for-a/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Telemedicine and Telehealth Implementation](https://scholariq.org/topics/telemedicine-and-telehealth-implementation/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.